Argos Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
46,957.80
56,239.90
7,906.30
52,973.40
15,188.80
Total Accounts Receivable
424.50
129.00
73.80
136.10
143.40
Other Current Assets
629.90
838.40
740.20
2,392.30
1,852.10
Total Current Assets
48,012.20
57,207.40
8,720.30
55,501.80
17,184.40
Net Property, Plant & Equipment
1,602.10
5,513.60
22,306.40
40,951.60
3,582.30
Total Investments and Advances
-
1,325.00
-
740.00
-
Other Assets
1,517.00
321.00
11.00
11.00
11.00
Total Assets
51,131.30
64,366.90
31,037.70
97,204.40
20,777.80
ST Debt & Current Portion LT Debt
45.40
30.90
1,578.30
11,598.40
7,322.60
Accounts Payable
1,317.10
1,860.50
2,907.70
5,377.40
970.70
Other Current Liabilities
1,800.80
1,405.40
3,676.80
13,634.10
1,263.90
Total Current Liabilities
3,163.30
3,296.80
8,162.80
30,609.80
9,557.20
Long-Term Debt
7,014.10
26,618.00
37,977.90
28,266.30
12,133.50
Deferred Taxes
3,066.00
-
-
-
-
Other Liabilities
-
3,100.30
13,098.40
32,158.60
8,321.10
Total Liabilities
13,243.40
33,015.10
59,239.10
91,034.70
30,011.80
Common Equity (Total)
75,776.60
31,351.80
28,201.40
6,169.70
9,234.10
Total Shareholders' Equity
37,887.90
31,351.80
28,201.40
6,169.70
9,234.10
Total Equity
37,887.90
31,351.80
28,201.40
6,169.70
9,234.10
Liabilities & Shareholders' Equity
51,131.30
64,366.90
31,037.70
97,204.40
20,777.80
Preferred Stock (Carrying Value)
113,664.50
-
-
-
-
About Argos Therapeutics
View Profile
